Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR Interference
Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research
FPX Nickel Receives Multi-Year Area-Based Permit and Commences 2025 Drilling Activities at Baptiste Nickel Project
